Efektivitas Terapi dan Adverse Drug Reactions (ADRs) Kombinasi Obat Antihipertensi pada Pasien Gagal Ginjal Kronis yang Menjalani Hemodialisis Rutin
Ummul Fadilah, Dr. dr. Probosuseno, Sp.PD-KGer., FINASIM., SE., MM., AIFO-K. ; Prof. Dr. apt. Agung Endro Nugroho, S.Si., M.Si.
2025 | Tesis | S2 Mag.Farmasi Klinik
Latar Belakang: Hipertensi
merupakan faktor risiko utama penyakit ginjal kronis (PGK) dan sering dijumpai
pada pasien hemodialisis. Penggunaan obat antihipertensi penting untuk
mengontrol tekanan darah, namun efektivitasnya dapat bervariasi tergantung
jumlah dan jenis kombinasi obat yang digunakan. Di sisi lain, pasien PGK juga
memiliki risiko tinggi mengalami adverse drug reactions (ADRs) akibat
gangguan fungsi ginjal dan kompleksitas terapi.
Tujuan: Penelitian ini bertujuan untuk
mengevaluasi efektivitas terapi antihipertensi dan insidensi ADRs pada pasien
GGK yang menjalani hemodialisis rutin berdasarkan jumlah kombinasi obat
antihipertensi (2 vs ?3).
Metode: Penelitian ini merupakan
kohort retrospektif dengan data primer dari wawancara pasien menggunakan
kuesioner (PERSYVE dan LCAT) dan data sekunder dari rekam medis pasien
hemodialisis rutin di RS Akademik UGM (Mei 2024 – Mei 2025). Subjek adalah
pasien ginjal kronis stadium 5 dengan hipertensi yang menerima ?2 obat
antihipertensi. Efektivitas terapi dievaluasi berdasarkan pencapaian target
tekanan darah <140>Liverpool Adverse Drug Reaction Causality Assesment
Tool (LCAT) dan skala keparahan
Hartwig. Analisis menggunakan uji t/Wilcoxon, Chi-square/Fisher, serta regresi
logistik biner.
Hasil: Pencapaian target tekanan
darah lebih tinggi pada kelompok kombinasi ?3 obat (35,3%) dibandingkan 2 obat
(22,2%) meskipun hubungan tersebut tidak signifikan (p = 0,268). Kelompok ?3
obat menunjukkan penurunan sistolik (? = 3,01 mmHg; p = 0,036) dan diastolik (?
= 2,53 mmHg; p = 0,014) signifikan secara intrakelompok, sedangkan antar
kelompok tidak berbeda bermakna. Kejadian ADR lebih banyak ditemukan pada
kelompok ?3 obat (25,8%) dibanding 2 obat (7,4%), dengan kecenderungan risiko
lebih tinggi (AOR=3,962), meski tidak signifikan secara statistik. Sebagian
besar ADR bersifat ringan, meliputi edema (20%) dan kantuk (20%).
Kesimpulan: Kombinasi ?3 obat antihipertensi terbukti menurunkan tekanan darah sistolik dan diastolik secara signifikan dalam kelompok, namun tidak lebih unggul dibandingkan kombinasi 2 obat dalam pencapaian target <140>
Background: Hypertension is a major risk
factor for chronic kidney disease (CKD) and is highly prevalent among patients
undergoing hemodialysis. Antihypertensive therapy plays a critical role in
blood pressure (BP) control, yet its effectiveness may vary depending on the
number and type of drug combinations. Patients with CKD are also at increased
risk of adverse drug reactions (ADRs) due to impaired renal function and
complex pharmacotherapy.
Objective: This study aims to evaluate the
effectiveness of antihypertensive therapy and the incidence of ADRs in CKD
patients undergoing routine hemodialysis based on different combinations of
antihypertensive medications.
Methods: A retrospective cohort study was conducted using primary data from patient interviews (PERSYVE questionnaire and LCAT) and secondary data from medical records of routine hemodialysis patients at Universitas Gadjah Mada Academic Hospital (May 2024–May 2025). Subjects included stage 5 CKD patients with hypertension receiving ?2 antihypertensive drugs. Treatment effectiveness was assessed by achieving blood pressure targets <140>
Results: The achievement of
target blood pressure was higher in the ?3 drug group (35.3%) compared to the
2-drug group (22.2%), althought the association was not statistically
significant (p=0.268). The ?3-drug group showed significant intragroup
reductions in systolic (?=3.01 mmHg; p=0.036) and diastolic blood pressure
(?=2.53 mmHg; p=0.014), while intergroup comparisons were not significant. ADRs
were more frequent in the ?3-drug group (25.8%) than in the 2-drug group
(7.4%), with a higher tendency of risk (AOR=3.962), although not statistically
significant. Most ADRs were mild, predominantly edema (20%) and drowsiness
(20%).
Conclusion: The combination of ?3 antihypertensive agents was found to significantly reduce both systolic and diastolic blood pressure within the group; however, it was not superior to dual therapy in achieving the target of <140>
Kata Kunci : hipertensi, gagal ginjal kronis, hemodialisis, antihipertensi, efektivitas, adverse drug reactions/ hypertension, chronic kidney disease, hemodialysis, antihypertensive, effectiveness, adverse drug reactions.